Skip to main content
. 2020 Nov 16;20:300. doi: 10.1186/s12890-020-01344-y

Table 4.

Predictive factors of COPD defined by spirometry

Characteristic Odds Ratio (95% CI) p-value
UNIVARIABLE MODEL
 Age / year 1.05 (1.03, 1.06) < 0.001
 Gender Male vs Female 1.39 (1.19, 1.63) < 0.001
 Education Level / unita 0.97 (0.92, 1.01) 0.14
 Age Started Smoking / year 1.01 (0.98, 1.03) 0.71
 Average Cigarettes / Day Smoked (Log-transformed) 1.24 (1.03, 1.49) 0.024
 Pack Years (Log-transformed) 1.49 (1.24, 1.79) < 0.001
 Presently a Smoker Yes vs No 1.25 (1.06, 1.47) 0.008
 Serious Attempt to Quit (of those who are presently a smoker) Yes vs No 1.19 (0.88, 1.61) 0.26
 # of Healthcare Professionals Asking About Smoking (of those who are presently a smoker) / time 0.85 (0.69, 1.06) 0.14
 Emphysema Extent by LDCT
None Reference < 0.001
Trivial 1.52 (1.24, 1.86)
Mild 2.20 (1.77, 2.74)
Moderate 2.58 (1.94, 3.44)
Severe 3.76 (2.42, 5.85)
Very Severe 14.76 (3.38, 64.47)
 Emphysema Distribution by LDCT None
Diffuse Reference < 0.001
Lower Lobe 1.60 (1.24, 2.06)
Upper Lobe 1.68 (0.73, 3.83)
2.19 (1.84, 2.60)
 Dyspnea Yes vs No 1.55 (1.32, 1.81) < 0.001
 Cough Yes vs No 1.23 (1.05, 1.44) 0.010
 Phlegm Yes vs No 1.19 (1.02, 1.40) 0.028
 Wheeze Yes vs No 1.43 (1.21, 1.68) < 0.001
 Any High Risk Occupation Yes vs No 1.25 (1.06, 1.47) 0.008
 Chest X-Rays ≥1 vs 0 1.24 (1.05, 1.45) 0.010
 CT Scans ≥1 vs 0 1.99 (1.23, 3.21) 0.005
 Number of Comorbiditiesb ≥1 vs 0 1.03 (0.83, 1.28) 0.77
MULTIVARIABLE MODEL
 Emphysema Extent
None Reference < 0.001
Trivial 1.51 (1.23, 1.86)
Mild 2.05 (1.64, 2.57)
Moderate 2.37 (1.77, 3.18)
Severe 3.09 (1.97, 4.86)
Very Severe 10.66 (2.40, 47.37)
 Age / year 1.06 (1.04, 1.07) < 0.001
 Dyspnea Yes vs No 1.33 (1.11, 1.59) 0.002
 Presently a Smoker Yes vs No 1.38 (1.15, 1.65) < 0.001
 Pack Years (Log-transformed) 1.34 (1.10, 1.63) 0.003
 Wheeze Yes vs No 1.25 (1.04, 1.51) 0.020
 Any High Risk Occupation Yes vs No 1.21 (1.02, 1.44) 0.030

aEducation was collected on a 7 level/unit scale, but grouped in Table 1 according to secondary and post-secondary completion

bComorbidities include coronary artery disease, angina, myocardial infarction, congestive heart failure, peripheral vascular disease, asthma, pneumonia, respiratory failure, and any cancer